IsoPlexis (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- September 25, 2017
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $13,500,000
Company Info
- Founders
- Sean Mackay
- Company Description
- IsoPlexis is a life science technology company that develops a single-cell detection system identifying patient immune responses.
- Market
- Immunity-based cancer treatments
- Location
- Branford, Connecticut, USA
- Coinvestors
- Connecticut Innovations, Ironwood Capital, North Sound Ventures, Spring Mountain Capital